The expression level of NAD-producing enzyme, NAMPT, is dramatically enhanced in cancer patients, particularly those with breast cancer (Dalamaga et al., 2018[9]; Sampath et al., 2015[22]). This evidence concerns the gene NAMPT and breast carcinoma.